Successful Desensitization to Lenalidomide in Leukocytoclastic Vasculitis

I Fernández-Concha; K Pose; L de Las Vecillas; M Lluch-Bernal; M Tomás-Pérez; T Soto; A López de la Guía; R Cabañas

doi:10.18176/jiaci.1002

Successful Desensitization to Lenalidomide in Leukocytoclastic Vasculitis

J Investig Allergol Clin Immunol. 2024 Oct 23;34(5):352-353. doi: 10.18176/jiaci.1002. Epub 2024 Jul 8.

Authors

I Fernández-Concha¹, K Pose¹, L de Las Vecillas^{1

2}, M Lluch-Bernal^{1

2}, M Tomás-Pérez^{1

2}, T Soto^{2

3}, A López de la Guía^{2

3}, R Cabañas^{1

2

4

5}

Affiliations

¹ Allergy Department, Hospital Universitario La Paz, Madrid, Spain.
² Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
³ Hematology Department, Hospital Universitario La Paz, Madrid, Spain.
⁴ PIELenRed consortium.
⁵ Center for Biomedical Research Network on Rare Diseases (CIBERER U754), Madrid, Spain.

PMID: 38976235
DOI: 10.18176/jiaci.1002

No abstract available

Keywords: Desensitization protocol; Lenalidomide; Leukocytoclastic vasculitis; Multiple myeloma.